About Clearsynth
Clearsynth is a company based in Mumbai (India) founded in 2009 by Vijay Ambati. Clearsynth has raised $4.81 million across 2 funding rounds from investors including SIDBI Venture Capital and Tulip Diagnostics. The company has 267 employees as of April 06, 2024. Clearsynth operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
- Headquarter Mumbai, India
- Employees 267 as on 06 Apr, 2024
- Founders Vijay Ambati
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Clearsynth Labs Limited
- Date of Incorporation 30 Mar, 2010
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$9.9 M (USD)62.26as on Mar 31, 2023
-
Net Profit
$121.51 K (USD)-74.15as on Mar 31, 2023
-
EBITDA
$1.25 M (USD)-28.6as on Mar 31, 2023
-
Total Equity Funding
$4.81 M (USD)
in 2 rounds
-
Latest Funding Round
$4.4 M (USD), Series A
Feb 20, 2022
-
Investors
SIDBI Venture Capital
& 1 more
-
Employee Count
267
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Clearsynth
Unlock access to complete
Funding Insights of Clearsynth
Clearsynth has successfully raised a total of $4.81M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.4 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Clearsynth
Clearsynth has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include SIDBI Venture Capital and Tulip Diagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital management for SMEs and startups in India.
|
Locked | Locked | Locked | |
|
IVD kits and instruments for infectious diseases and clinical chemistry
|
Locked | Locked | Locked |
Investor details for Clearsynth
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clearsynth
Investment portfolio details for Clearsynth
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Clearsynth
Detailed financials for Clearsynth
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clearsynth Comparisons
Peer comparison for Clearsynth
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Clearsynth
Clearsynth operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services for small molecules are provided.
|
|
| Locked | Locked | Locked |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| Locked | Locked | Locked |
Generic drugs and clinical research services are provided globally.
|
|
| Locked | Locked | Locked |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
|
| Locked | Locked | Locked |
Novel point-of-care testing and low-dose interferon therapeutics are developed.
|
Detailed competitors of Clearsynth
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clearsynth
Complete news archive for Clearsynth
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clearsynth
Clearsynth was founded in 2009 and raised its 1st funding round 11 years after it was founded.
Clearsynth is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Vijay Ambati is the current CEO of Clearsynth. They have also founded this company.
Clearsynth is a funded company, having raised a total of $4.81M across 2 funding rounds to date.
As of Apr 06, 2024, the latest employee count at Clearsynth is 267.
Annual revenue of Clearsynth is $9.9M as on Mar 31, 2023.
Clearsynth was founded in 2009 in Mumbai, India, as a contract development and manufacturing organization (CDMO) in the pharmaceutical sector. Operations center on the production of small molecule active pharmaceutical ingredients (APIs) alongside analytical research and development services. These activities support global clients through custom synthesis, process development, and quality control testing, with facilities located in India to ensure regulatory compliance and scalable manufacturing.
Clearsynth has 2 investors. Key investors include SIDBI Venture Capital, and Tulip Diagnostics.
The valuation of Clearsynth is $49.85M as of Feb 2022.